Theranos founder Elizabeth Holmes documentary opens with $15M in North America
- You Can See Everything achieves biggest non-music documentary debut in more than two decades

Loading…
- You Can See Everything achieves biggest non-music documentary debut in more than two decades

By Dilara Hamit
ANKARA (AA) – You Can See Everything, a documentary about disgraced Theranos founder Elizabeth Holmes, earned an estimated $15 million during its opening weekend in North America, distributor A24 said.
The result was the biggest opening for a non-music documentary since Michael Moore’s Fahrenheit 9/11 took nearly $24 million from 868 theaters in 2004.
Directed by Nathan Fielder and Lance Oppenheim, the two-hour-and-55-minute film opened in only 855 theaters across the US and Canada. More than 2,000 screenings sold out over the weekend, according to A24.
Its average earnings of approximately $17,544 per theater were more than double those of Street Fighter, which topped the North American box office with $31 million from 3,575 locations. Box-office data placed the documentary second overall for the weekend.
You Can See Everything also recorded the biggest opening for a film playing in fewer than 1,000 theaters since Borat launched with $26.5 million in 2006.
The film was made largely in secret over three years and follows Holmes during the weeks before she entered federal prison in 2023. A24 describes it as beginning when Holmes invited a skeptical film crew to record her final 34 days before reporting to prison.
The documentary includes Holmes’ partner, Billy Evans, and their two children and examines how the former Silicon Valley executive sought to present herself after the collapse of Theranos.
Holmes was convicted in 2022 of defrauding investors in the blood-testing company, which had claimed it could perform numerous medical tests using only small quantities of blood.
The strong opening followed widespread critical attention and positive audience reactions. More than 70% of the opening-weekend audience was reportedly under 35, suggesting that younger moviegoers helped drive demand for the unusually long documentary.
The film has yet to begin its wider international rollout. It is scheduled to open in Australia on Nov. 12 and Britain on Nov. 20.